AVADEL SPECIALTY PHARMACEUTICALS, LLC Binding Agreement on the Terms and Conditions for $2,700,000 Unsecured Debtor-In-Possession Credit FacilityBinding Agreement • February 14th, 2019 • Avadel Pharmaceuticals PLC • Pharmaceutical preparations • New York
Upon the full execution of this agreement, the terms and conditions set forth herein and any related exhibits, schedules and/or annexes (this “Agreement”) shall become binding upon Avadel US Holdings, Inc., a Delaware corporation (the “Lender”), and Avadel Specialty Pharmaceuticals, LLC, a Delaware limited liability company (the “Debtor” or the “Borrower”), subject to Bankruptcy Court (as defined below) approval and certain other terms and conditions, as expressly set forth below. This Agreement reflects the terms for an unsecured debtor-in-possession credit facility to be provided by Lender for Borrower in its bankruptcy case to be filed under Chapter 11 of Title 11 of the United States Code (the “Bankruptcy Case”).
